Chenodeoxycholic Acid

Overview

Chenodeoxycholic Acid is a hydrophobic primary bile acid that activates nuclear receptors ( FXR ) involved in cholesterol metabolism.

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Autophagy | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > FXR | Products > Signaling Pathways > Endogenous Metabolite | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-76847
• CAS No.: 474-25-9
• Molecular Formula: C24H40O4
• Molecular Weight: 392.57
• Purity: 99.93%
• Storage: RT, protect from light. In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: 2.5 mg/mL (6.37 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source